Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accumulated, achieve, achievement, acute, aggregate, AOCI, appellate, area, awarded, benchmark, book, broadly, Canadian, chronic, coinciding, compounding, contaminant, cumulative, deliver, device, directly, discipline, discretionary, dosing, earned, EITF, element, entirety, entity, equal, exceed, expedite, Fact, floating, Force, formally, GAMMAGARD, grouped, highly, inception, input, invoiced, Japan, joint, KIOVIG, law, life, lifting, manner, mid, notional, obligor, OCI, opportunity, percent, pharmacy, phase, portion, postretirement, precise, promotional, reclassified, redeemed, reform, reliable, reversed, safe, shareholder, shock, SIGMA, similarly, Spectrum, split, stage, stake, steering, strategy, Task, taxation, undesignated
Removed:
abdominal, abroad, acquiring, acquisition, added, advanced, affiliate, allergic, analyzing, annualized, annually, Asia, assessment, attention, autism, automated, back, BeneFIX, bloodstream, body, candidate, capitalization, center, childhood, choose, cleansed, close, consist, contracted, converted, decided, declined, deficit, desflurane, develop, dialyzer, disorder, Disposal, driver, earliest, Eastern, elimination, emphysema, evaluate, executing, exit, expand, expanded, expectation, expensing, experience, extended, external, fairly, filter, fiscal, FIX, flat, fluctuate, fluid, FSME, funded, generated, granting, Halozyme, hereditary, hierarchy, hyaluronidase, HYLENEX, Immun, influenza, initial, integrate, irrevocable, lining, machine, manual, manufactured, meaningful, membrane, Mexico, mirror, molecule, monitoring, North, nutritional, opposition, optimize, outpatient, Parallel, parent, patch, PEGylation, penetration, people, pertaining, plant, prepayment, preservative, prevention, prohibited, propofol, proprietary, prospective, pumped, qualify, qualitative, quantitative, recognize, recommercialization, reconstituted, refined, relation, remove, represented, revenue, revised, revoke, separation, service, set, slightly, small, software, specialty, Specifically, stated, stoppage, SUPRANE, surgical, TachoSil, tender, testing, Teva, thimerosal, timeline, TPG, transfer, treatment, tubing, upfront, upgrade, USP, waste, weakening, workforce, worldwide, write, Wyeth
Filing tables
Filing exhibits
Related press release
BAX similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
Robert L. Parkinson, Jr., as Chairman of the Board and Chief Executive Officer of Baxter International Inc. (the “Company”), certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes–Oxley Act of 2002, that:
(1) | the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2009 as filed with Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and | ||
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Robert L. Parkinson, Jr. | ||
Robert L. Parkinson, Jr. | ||
Chairman of the Board and Chief Executive Officer | ||
May 5, 2009 |